{"name":"Validus Pharmaceuticals","slug":"validus-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Extended-release carbamazepine","genericName":"Extended-release carbamazepine","slug":"extended-release-carbamazepine","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Extended-release carbamazepine","genericName":"Extended-release carbamazepine","slug":"extended-release-carbamazepine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNUWJnTDQ3ckpjdmxQa2IzdXYwU0lUM1FwaHRKcW1VRjNuS2NtcmhWczlWcl9ac0xpTzF3cWJBUEJIb3BHREppT3ZlZW9CbFhld293TS0tdV9vUWFyS3o4QVplOUJWNTc2MWdCNEFGS3FtVF9TOC1DS2NwaEZaQ050SndpUlNLU2hyMHZ6YVhTRlJnTS1ET0E?oc=5","date":"2025-10-20","type":"pipeline","source":"lupin.com","summary":"Lupin Launches Bumetanide Injection, USP in the United States - lupin.com","headline":"Lupin Launches Bumetanide Injection, USP in the United States","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOUlNEYTBkS2p2QWdwaVZROE52bEc2MjdHWm13YnFBTkdXMG5wNlYxcDZRWkVCelRRZy1sMTdzLUVYMnFPaTl6Wk56eDc1M0s0QVN3RFIzd19GU1ljVkhjblNkZ3BfLTRlekQ0MklURlg5R0k0TkdFSDJhZDc1SUtVdEFTcmVUWW1wc3psSlRNdktFcG9SaEZSc2RUajc?oc=5","date":"2025-10-17","type":"regulatory","source":"lupin.com","summary":"Lupin Receives Approval from U.S. FDA for Bumetanide Injection, USP - lupin.com","headline":"Lupin Receives Approval from U.S. FDA for Bumetanide Injection, USP","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-10-09","type":"pipeline","source":"The Economic Times","summary":"Rubicon Research IPO: Check GMP, brokerages review, subscription and other details - The Economic Times","headline":"Rubicon Research IPO: Check GMP, brokerages review, subscription and other details","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1heVBxWUNNc1pBNEFWSW9RSVV1NldfalpJTjFZY2Q2M1oxcDBpZGpKdmdWUTM4cHFSaDNSWDIzU3lsbm5qMllDUzBoT2NfcmZ0TUNiOTNiU2NSUmZFSEJN?oc=5","date":"2025-10-06","type":"pipeline","source":"IPO Central","summary":"Rubicon Research IPO Review: Fastest-Growing, U.S.-Dominating Pharma Play, Time to Invest? - IPO Central","headline":"Rubicon Research IPO Review: Fastest-Growing, U.S.-Dominating Pharma Play, Time to Invest?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQU1JQMGpPZjRmSldFWUJxUUNocE05LXU4VV9PdVp5U2V3cDJVa1YtRXRIYjlhbWdHY3d5a0dCd1NUUnhOUGlnRGYzcWk5d3N2eEpzNzJya21WWFRvcHBjNG1ITk5OQjFxOHl0Y3l5TXV5dGhaUDlSaWtfQ09pSGlhdWFCMmJnUHFyRG1mVU5oSVdDQQ?oc=5","date":"2025-04-21","type":"pipeline","source":"Insightace Analytic","summary":"Peptide�drug Conjugates (PDCs) Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Peptide�drug Conjugates (PDCs) Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-09-19","type":"regulatory","source":"Medical Dialogues","summary":"Lupin bags USFDA nod for Bumetanide Injection for edema treatment - Medical Dialogues","headline":"Lupin bags USFDA nod for Bumetanide Injection for edema treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPTlZwT3g3TVZacXczeDRpRV81TncxeG1NN282Q1luTExqbk9DblA0Q1BQLUdmZ3FtUDc4V1UwMXRjV3ZTaUlwSlU5Z3luNlZROEZJZ0VOaGdlU2dqRkVmbTVnOE9OaWhkam1HTWFqcHg5RFFzdGFYMUVXUEJWaVBoYkVReklORmvSAYwBQVVfeXFMTTVoUDJRWEVGZDVKWFVCb2ZlbDlyMTNRVFlxcWZqUHVkbWZUNmYzVk10M0FILS1mTkpJVUc5WVVkaGhveEhHeFlkZHQwV21wOGJMMUhDM004ME5tVWpqM18yNDE5TnpDUlBHS21wTTZzZ2Y0ZmRhOGVCcjdYSEdmVFFXTXBVbUxCVFZZOVE?oc=5","date":"2024-09-18","type":"regulatory","source":"Express Pharma","summary":"Lupin gets US FDA nod for Bumetanide Injection, USP - Express Pharma","headline":"Lupin gets US FDA nod for Bumetanide Injection, USP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNVGRmZjdONkRtV2thd2ZLX1JZSmNBWFJmY044Q0I3M2I4YkNOcVVCUmpiQkd3OFdpWnZmNkNEc2d4WFhzeFBJWXlPZW5ZMkstenhhTmNIcUNObUVCNDFBVVR5dTk0dnJSMTlDRjBwVnJRM3NvUElyTWFMRklJQm8wWTczdHBfWnhpbS1rY05QdzgtSjFKZHF1Q3ZVaTZobXBDUVlhNzJRcHpJcGRIQ3VsdzNtY3phNlo5YXZ1WE5iRFNoUTRKS1HSAc4BQVVfeXFMTUwxUGxwLUh0cmZZdjVXODQ1ZVpDSjJuZ2ZPd2dSaHl0VklRdks1VGc2TzhQNVdlLWJlNEVUajYtQVJVdnZIT3gwdzVrQUxwVUVsVzBEeDNmUTRTT0U5YjE4ZUprZkgxRWZBVUZNVlNGQ1F4X0trbHJfY2VZNnltVi1XbTRtNGZ3cV9XY0pMVGhQak9yVXRlcld4d2RrVktrSDhJMmtNY2tHVTZFcUJ5a3lFYnEzcEl3NkE2ekR4NzVkTk0yZi1aMWNzNVB0dVE?oc=5","date":"2023-12-15","type":"regulatory","source":"ANI News","summary":"Lyrus Receives US FDA Approval for Critical UTI Treatment in the US - ANI News","headline":"Lyrus Receives US FDA Approval for Critical UTI Treatment in the US","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNc0NfYjN2cXNnMzZZVE5UY293QVBmWWlDd0ZyUTU5WTBGYWluT3hZQUd3UGxyeXViaUFBOE9hNzdNb0ZmSkZNanViQ004bjlKQlFMNVZsWlJtWmhlRVFzZnhXR0lXQzdDX1F3d19uZXJSMkVWVFJXYVlacUhlUTBFVG5hcmY0dTBCVVZ2dlZTRTFoYlBkZVZ3Z0ZOdFlJd0VNOGlmbTBFZFdhRGNoWHBHcWlNVHR4UnFESmRaN1ZnTmZXLTdTcHB5blM0RQ?oc=5","date":"2023-07-28","type":"pipeline","source":"Pharmacy Practice News","summary":"ISMP Updates Often Confused Drug Names List - Pharmacy Practice News","headline":"ISMP Updates Often Confused Drug Names List","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNYmI0Uk1ZaGVqekdWd1NlYXkxTmNtQjJrVXFFSWtPY3NlTmQ3Rmgzb2VuQ01EQkpTNkhUaHNoeHBCbWJadms4Snpub3VRSVd6ZkNnUDVKMnkyWjc2UDFzVFlHQ0JJRlUyMEhnUDNqTHZiNGcxR2hMS2p1QzdKaEFDblNnX3ZJUGh6ckdLaTAwVlN2ZjIwRkZoRUwzdXIxUQ?oc=5","date":"2022-08-20","type":"patent","source":"managedhealthcareexecutive.com","summary":"Akorn, Ani and Novadoz Launch New Generic Products - managedhealthcareexecutive.com","headline":"Akorn, Ani and Novadoz Launch New Generic Products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQeW1WUXFsQTM2OG04QkFLZU1id0g5TXctODdhcVh5V3B1cjNUZmh2SUNnUFk5Y2FGV3FWcUFCc1NLaTFsRDZxblBMRlg5X08zdkNfUVhObGNTblpZbGQzbHlqdm9iWjBRaUpmTWs3bFpVZEFEdVdBNVdLQzdTUm0xejNCQmtfbHN0S3FwU3Z3?oc=5","date":"2021-03-01","type":"pipeline","source":"The Italian Tribune","summary":"Dr. Guarino Picked as Top Pharmaceutical Executive of the Year - The Italian Tribune","headline":"Dr. Guarino Picked as Top Pharmaceutical Executive of the Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNSDltTE1VRTl0cUxkbGdPNFlIMWxSNG92SjNEMlR5M3Rhd3hGZzEwWmc1dm5RcDhQeUNpYTh1RmI1a09ENVZYOUp1NEhXWGUxSldVTUpaVXlBUnVQbzliNkd5bjhRYS1QU24zd3prWXRUaWx5YlI2akVOX3FvVXMyRmVOZnNIX09DMmNXWXM4cXg5ZmxpZERrUEt4RWhKMDNpZmdiVG9aY3FsS0FJ?oc=5","date":"2016-09-15","type":"pipeline","source":"BioProcess International","summary":"The Virtual Pharmaceutical Company: A New Pathway to Market? - BioProcess International","headline":"The Virtual Pharmaceutical Company: A New Pathway to Market?","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}